Skip to main content

Table 2 HPyV6 and HPyV7 prevalence in non-cutaneous human malignancies

From: Development of a novel multi‑epitope vaccine against the pathogenic human polyomavirus V6/7 using reverse vaccinology

Tumor type

HPyV6 Positive

HPyV7 Positive

Reference

Laryngeal squamous cell carcinoma

14.3%

Not detected

[17]

Thymic epithelial tumors

Not detected

62.2%

[18]

Cholangiocarcinoma

9.5%

45.2%

[19]

  1. (Adapted from [7])